Vibration Exercise for Crohn's to Observe Response

NCT ID: NCT06211400

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

168 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-31

Study Completion Date

2028-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Crohn's disease (CD) is a long-term inflammatory condition of the digestive system. People with CD often have unpredictable and debilitating symptoms, including abdominal pain, diarrhoea and fatigue. In addition, they require long-term treatment with frequent negative effects and often need surgery and hospitalisations. Therefore, people with CD report a lower health-related quality of life (HRQOL) compared with other people. Doctors are constantly trying to find new treatments to improve HRQOL and control symptoms and whole body vibration exercise could be a potential treatment.

Exercise might be a simple, safe, and low-cost intervention for improving HRQOL in people with CD. This is because it has the potential to improve several aspects of physical, mental and social well-being simultaneously. Adults with CD have been shown to be less active than the general population and do not meet the recommended daily physical activity guidelines. One barrier to exercise is lack of time, however whole-body vibration exercise (where you stand and squat on a vibrating plate) can be done over a much shorter duration and at a lower intensity to gain potentially similar or at times greater benefits. More research is needed to understand the effects, both positive and negative of vibration exercise in people with CD.

Aim: This study begins to understand whether undertaking a supervised 6-week vibration exercise programme for adults with mild to moderately active Crohn's disease improves HRQoL and other symptoms such as fatigue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vibration Exercise

Group Type EXPERIMENTAL

Whole body vibration exercise

Intervention Type OTHER

6-week supervised whole body vibration exercise programme (training sessions three times per week lasting 10 min) alongside a lifestyle education programme

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole body vibration exercise

6-week supervised whole body vibration exercise programme (training sessions three times per week lasting 10 min) alongside a lifestyle education programme

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged over 18-65 years old
* Clinical diagnosis of CD for at least 4 weeks before randomization

* Mild to moderate active CD (150-220 CDAI)
* Stable medication for at least 4 weeks before randomization
* Able to provide written consent, complete the study questionnaires and travel to the research centre for study assessment visits and exercise sessions
* Be doing less than 60 minutes of purposeful exercise per week

Exclusion Criteria

* Over 65 years old Severe or uncontrolled medical conditions that make it undesirable for the patient to participate

* Coexistent serious autoimmune disease such as rheumatoid arthritis or systemic sclerosis
* Planned major surgery within the first 3 months after randomization
* Are pregnant, or are planning pregnancy within the first 3 months after randomization
* Poor tolerability to venepuncture or lack of adequate venous access for required blood sampling
* Current participation in \>60 min/week of purposeful exercise, such as jogging or cycling
* Participation in another clinical trial for which concurrent participation is deemed inappropriate
* Any orthopaedic implants (hip, knee, spine)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Central Lancashire

OTHER

Sponsor Role collaborator

Anglia Ruskin University

OTHER

Sponsor Role collaborator

University of Hertfordshire

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Hertfordshire

Hatfield, UK, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lindsay Bottoms

Role: CONTACT

+441707285685

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lindsay Bottoms

Role: primary

+441707285685

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VECTOR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Health Benefits of Tart Cherry in Crohn's Disease
NCT06901986 NOT_YET_RECRUITING NA